Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_assertion type Assertion NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_head.
- NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_assertion wasGeneratedBy ECO_0000203 NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_provenance.
- NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_assertion wasDerivedFrom befree-2016 NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_provenance.
- NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_assertion SIO_000772 20447716 NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_provenance.
- NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_assertion evidence source_evidence_literature NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_provenance.
- NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_assertion description "[Sorafenib induces the suppression of collagen accumulation and HSC growth warranting the use of sorafenib as a potential therapeutic agent in the treatment of liver fibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810427.RAXbwv9yiQxhKQu0PkMdpBj60MnY_6ckvDVRwPu1865VU130_provenance.